Search results for " Dose"

showing 10 items of 593 documents

Cuticular hydrocarbon profiles in Blattella germanica: effects of halofenozide, boric acid and benfuracarb

2006

1379-1176 (Print) Journal Article; In order to complete previous studies conducted on Blattella germanica, three insecticides from different groups were evaluated: boric acid, an inorganic compound, benfuracarb, a carbamate, and halofenozide, a non-steroidal ecdysone agonist. Boric acid (8.20%, LD50) and benfuracarb (2%, LD50) were incorporated into the diet and orally administrated to newly emerged adults of both sexes, while halofenozide (0.33%, LD50) was applied topically. Hydrocarbons extracts was made on bidistilled pentane from control and treated series sampled 6 days following treatment. Extracts was analyzed by gas chromatography. Data showed that cuticular profiles of control and …

OralMaleChromatographyHydrazines/*toxicityTime Factorsintegumentary systembeta-Alanine/*analogs & derivatives/toxicityHydrocarbons/*analysisBenzofurans/*toxicityBenzoic Acids/*toxicityLethal Dose 50TopicalInsecticides/*toxicityBoric Acids/*toxicityGasAdministrationAnimalsFemaleBlattellidae/chemistry/drug effects/growth & development
researchProduct

Dosing fentanyl buccal tablet for breakthrough cancer pain: dose titration versus proportional doses.

2012

Abstract OBJECTIVES: The aim of this study was to compare the efficacy and safety of doses of fentanyl buccal tablet (FBT) proportional to doses of opioids used for background analgesia versus dose titration starting with the minimal dose for the management of breakthrough cancer pain (BTcP). METHODS: A total of 82 cancer patients with BTcP who were receiving strong opioids in doses of at least 60 mg of oral morphine equivalents and having acceptable background analgesia, were selected for a multicenter unblinded study. Forty-one patients were randomized to receive FBT in doses proportional to the daily opioid doses for four consecutive episodes of BTcP (group P). Forty-one patients underwe…

OralMaleDose titrationfentanyl buccal tabletAdministration OralOpioidDosing fentanylSettore MED/42 - Igiene Generale E ApplicataDose titrationlaw.inventionDose-Response RelationshipRandomized controlled triallawNeoplasmsFentanyl Buccal TabletMedicineHumansRapid onset opioidsDrug Dosage CalculationsCancer painAgedPain MeasurementAnalgesicsDose-Response Relationship DrugBreakthrough pain; Cancer pain; Dose titration; Fentanyl buccal tablet; Rapid onset opioids; Administration Oral; Aged; Analgesics Opioid; Breakthrough Pain; Dose-Response Relationship Drug; Female; Fentanyl; Humans; Male; Middle Aged; Neoplasms; Pain Measurement; Tablets; Titrimetry; Drug Dosage Calculations; Medicine (all)business.industryMedicine (all)Breakthrough PainTitrimetryCancerGeneral MedicineBuccal administrationfentanyl buccal tablet; breakthrough cancer pain; randomized clinical trialMiddle Agedmedicine.diseaserandomized clinical trialAnalgesics OpioidFentanylbreakthrough cancer painOpioidAnesthesiaAdministrationFemaleDrugbusinessCancer painmedicine.drugTabletsCurrent medical research and opinion
researchProduct

Dosimetric characteristics of a new unit for electronic skin brachytherapy

2013

PURPOSE: Brachytherapy with radioactive high dose rate (HDR) (192)Ir source is applied to small skin cancer lesions, using surface applicators, i.e. Leipzig or Valencia type. New developments in the field of radiotherapy for skin cancer include electronic brachytherapy. This technique involves the placement of an HDR X-ray source close to the skin, therefore combining the benefits of brachytherapy with the reduced shielding requirements and targeted energy of low energy X-rays. Recently, the Esteya(®) Electronic Brachytherapy System (Esteya EBS, Elekta AB-Nucletron, Stockholm, Sweden) has been developed specifically for HDR brachytherapy treatment of surface lesions. The system provides rad…

Original Paperelectronic brachytherapybusiness.industrymedicine.medical_treatmentTreatment durationSuperficial radiotherapyBrachytherapyElectronic skinsuperficial radiotherapyRadiation therapyLow energyOncologynonmelanoma skin-cancermedicineskin brachytherapyRadiology Nuclear Medicine and imagingNuclear medicinebusinessDose rateDepth doseJournal of Contemporary Brachytherapy
researchProduct

MCC1019, a selective inhibitor of the Polo-box domain of Polo-like kinase 1 as novel, potent anticancer candidate

2019

Polo-like kinase (PLK1) has been identified as a potential target for cancer treatment. Although a number of small molecules have been investigated as PLK1 inhibitors, many of which showed limited selectivity. PLK1 harbors a regulatory domain, the Polo box domain (PBD), which has a key regulatory function for kinase activity and substrate recognition. We report on 3-bromomethyl-benzofuran-2-carboxylic acid ethyl ester (designated: MCC1019) as selective PLK1 inhibitor targeting PLK1 PBD. Cytotoxicity and fluorescence polarization-based screening were applied to a library of 1162 drug-like compounds to identify potential inhibitors of PLK1 PBD. The activity of compound MC1019 against the PLK1…

PBD Polo box domainMTD maximal tolerance doseCDC25 cell division cycle 25HIF-1α hypoxia-inducible factor 1 αMST microscale thermophoresisIC50 50% inhibition concentrationMFP M phase promoting factorPARP-1 poly(ADP-ribose) polymerase-10302 clinical medicineFOXO forkhead box ONec-1 necrostatin 1CDC2 cell division cycle protein 2 homologGeneral Pharmacology Toxicology and PharmaceuticsMitotic catastropheCDK cyclin-dependent kinase0303 health sciencesChemistryPolo-like kinaseMono-targeted therapyCell cycleBUBR1 budding uninhibited by benzimidazole-related 1Polo box domain030220 oncology & carcinogenesisPLK1 Polo-like kinaseNecroptosisSpindle damagePLK1IHC immunohistochemistryOriginal articleNecroptosisCell cyclePLK1APC/C anaphase-promoting complex/cyclosomePLK3ABC avidin-biotin complexPI propidium iodide03 medical and health sciencesFBS fetal bovine serumPDB Protein Data BankKd the dissociation constantKinase activity030304 developmental biologyAkt/PKB signaling pathwayCell growthlcsh:RM1-950LC3 light chain 3lcsh:Therapeutics. PharmacologyCancer researchDAPKs death-associated protein kinase3-MA 3-methyladenineDAPI 4′6-diamidino-2-phenylindoleSAC spindle assembly checkpointActa Pharmaceutica Sinica B
researchProduct

Photoinduced toxicity of retene to Daphnia magna under enhanced UV-B radiation.

2001

Abstract The effects of UV radiation on the acute toxicity of retene (7-isopropyl-1-methylphenanthrene) to Daphnia magna Straus were studied. Dehydroabietic acid (DHAA) from which retene is formed in the vicinity of pulp and paper industry was also studied. Pyrene, anthracene, and phenanthrene were used as model PAH compounds. The time taken for immobilization (ET50) was monitored under biologically effective UV-B dose rates of 240, 365, 565, and 650 mW m−2 (UV-A and visible light also present). Median effective concentrations (EC50) were determined after a 15-min UV exposure (565 mW m−2) followed by 24 h in the dark. Retene ( 10–320 μg l −1 ) was not acutely toxic in the dark. The inductio…

PaperEnvironmental EngineeringPhotochemistryUltraviolet RaysHealth Toxicology and MutagenesisDaphnia magnaIndustrial WasteAbsorptionLethal Dose 50chemistry.chemical_compoundEnvironmental ChemistryOrganic chemistryAnimalsPolycyclic Aromatic HydrocarbonsAnthraceneRetenebiologyPublic Health Environmental and Occupational HealthGeneral MedicineGeneral ChemistryPhenanthrenePhenanthrenesbiology.organism_classificationPollutionAcute toxicitychemistryDaphniaToxicityAbietanesPyreneDiterpenesPhototoxicityWater Pollutants ChemicalNuclear chemistryChemosphere
researchProduct

Impact of medical imaging on the epigenome – low-dose exposure in the course of computed tomography does not induce detectable changes of DNA-methyla…

2021

Computed tomography (CT) is a main contributor to artificial low-dose exposure. Understanding the biological effects induced by CT exposure and their dependency on the characteristics of photon spectra is essential for knowledge-driven risk assessment. In a previous gene expression study, we have identified upregulation of AEN, BAX, DDB2, EDA2R and FDXR after ex vivo exposure with single-energy CT and dual-energy CT (DECT). In this study, we focused on CT-induced changes of DNA methylation. This epigenetic modification of DNA is a central regulator of gene expression and instrumental in preserving genome integrity. Previous studies reported focal hypermethylation and global hypomethylation …

Pathologymedicine.medical_specialtyBlood CellsRadiological and Ultrasound Technologymedicine.diagnostic_testbusiness.industryLow doseComputed tomographyEpigenomeDNA MethylationPeripheral bloodEpigenomeDNA methylationMedical imagingHumansMedicineRadiology Nuclear Medicine and imagingTomography X-Ray ComputedbusinessEpigenomicsInternational Journal of Radiation Biology
researchProduct

Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combi…

2006

Abstract Background To evaluate immunogenicity, reactogenicity, and safety of a hexavalent combination vaccine diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus- Haemophilus influenzae type b (DTPa-HBV-IPV/Hib) when coadministered with a 7-valent pneumococcal conjugate vaccine (PCV7). Methods Infants received either a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus- H. influenzae type b vaccine concomitantly with PCV7 or DTPa-HBV-IPV/Hib alone infants were vaccinated at 2, 3 and 4 months (primary immunization) and 12–15 months of age (booster dose). Local and systemic reactions and adverse events were monitored following each do…

Pediatricsmedicine.medical_specialtyPopulationBooster doseDiphtheria-Tetanus-acellular Pertussis Vaccinescomplex mixturesPneumococcal conjugate vaccinePneumococcal VaccinesmedicineHumansHepatitis B VaccinesVaccines CombinededucationWhooping coughBacterial CapsulesHaemophilus Vaccineseducation.field_of_studyReactogenicityGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryTetanusDiphtheriaPolysaccharides BacterialPublic Health Environmental and Occupational HealthInfantmedicine.diseaseVaccinationPoliovirus Vaccine InactivatedInfectious DiseasesImmunologyAntibody FormationMolecular MedicineImmunizationbusinessmedicine.drugVaccine
researchProduct

Aspetti etici e controllo di gestione dei farmaci antibiotici antibatterici

2010

Summary Introduction Antibacterial prescribing practices between 2004 and 2008 were investigated in the P. Giaccone University Hospital in Palermo, Italy to provide a foundation for critical analysis of the appropriateness of health-care resource usage. Materials and methods Antibiotic prescribing practices between 2004 and 2008 were analyzed in the hospital as a whole and in different specialty areas. Results were expressed as defined daily doses (DDD) as a function of bed-days, number of admissions, and Diagnosis Related Group (DRG) points. Results During the study period, increases were observed in the overall DDD per 100 bed-days (68.7 vs. 91.3) and the DDD per admission (4.53 vs. 5.54)…

Pediatricsmedicine.medical_specialtySettore MED/09 - Medicina Internabusiness.industryDiagnosis-related groupGeneral MedicineAmoxicillinMeropenemSettore MED/02 - Storia Della MedicinaCiprofloxacinAntibiotic therapy Ethics Management Defined Daily Doses (DDD)LevofloxacinChemoprophylaxisSettore BIO/14 - FarmacologiamedicineCeftriaxoneMedical prescriptionbusinessmedicine.drugItalian Journal of Medicine
researchProduct

Tryptophan immunoadsorption during pregnancy and breastfeeding in patients with acute relapse of multiple sclerosis and neuromyelitis optica.

2017

Background: Up to every fourth woman with multiple sclerosis (MS) or neuromyelitis optica spectrum disorder (NMOSD) suffers a clinically relevant relapse during pregnancy. High doses of steroids bear some serious risks, especially within the first trimester of pregnancy. Immunoadsorption (IA) is an effective and more selective treatment option in disabling MS relapse than plasma exchange. Data on the use of IA during pregnancy and breastfeeding are scarce. Methods: In this retrospective multicenter study, we analyzed the safety and efficacy of IA treatment in acute relapses during pregnancy or breastfeeding. The primary outcome parameter - change of acute relapse-related disability after IA…

Pediatricsmedicine.medical_specialtybreastfeedingBreastfeeding030204 cardiovascular system & hematologymultiple sclerosislcsh:RC346-42903 medical and health sciences0302 clinical medicineplasma exchangeHigh dosesMedicineIn patientSpectrum disorderImmunoadsorptionlcsh:Neurology. Diseases of the nervous systemOriginal ResearchPharmacologyrelapsePregnancytherapyNeuromyelitis opticabusiness.industryMultiple sclerosisneuromyelitis optica spectrum disordermedicine.diseaseeye diseasesNeurologyNeurology (clinical)pregnancybusiness030217 neurology & neurosurgeryimmunoadsorptionTherapeutic advances in neurological disorders
researchProduct

Induction of micronuclei in V79 Chinese hamster cells by tetrachlorohydroquinone, a metabolite of pentachlorophenol

1992

Tetrachlorohydroquinone, a metabolite of the fungicide pentachlorophenol, induced significant dose-related increases in micronuclei in V79 Chinese hamster cells without exogenous metabolic activation. The lowest observed effective dose was 10 microM, where the relative survival was about 62%. At the highest dose tested, 20 microM, the relative survival was about 8% and the frequency of cells with micronuclei was about 6 times the solvent control frequency. The induction of micronuclei by tetrachlorohydroquinone was significantly inhibited by the hydroxyl radical scavenger dimethyl sulfoxide at 5% (v/v).

PentachlorophenolMetaboliteHamsterToxicologycomplex mixturesChinese hamsterchemistry.chemical_compoundCricetulusCricetinaeGeneticsAnimalsDimethyl SulfoxideCells CulturedMicronuclei Chromosome-DefectiveCarcinogenMicronucleus TestsbiologyDimethyl sulfoxidebiology.organism_classificationMolecular biologyEffective dose (pharmacology)HydroquinonesPentachlorophenolchemistryBiochemistryMicronucleus testDNA DamageMutation Research/Genetic Toxicology
researchProduct